Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Review
. 1999 Oct;89(4 Suppl):7.
doi: 10.1097/00000539-199910001-00003.

A review of the pharmacokinetics and pharmacodynamics of remifentanil

Peter S A Glass  1 , Tong J Gan, Scott Howell
Affiliations
Review

A review of the pharmacokinetics and pharmacodynamics of remifentanil

Peter S A Glass et al. Anesth Analg. 1999 Oct.
No abstract available

PubMed Disclaimer

References

    1. James MK, Vuong A, Grizzle MK, et al. Hemodynamic effects of GI87084B, an ultra-short acting mu-opioid analgesic, in anesthetized dogs. J Pharmacol Exp Ther 1992; 263: 84–91.
    1. James MK, Feldman PI, Schuster SV, et al. Opioid receptor activity of GI87084B, a novel ultra-short acting analgesic, in isolated tissues. J Pharmacol Exp Ther 1991; 259: 712–8.
    1. Amin HM, Sopchak AM, Esposito BF, et al. Naloxone-induced and spontaneous reversal of depressed ventilatory responses to hypoxia during and after continuous infusion of remifentanil and alfentanil. J Pharmacol Exp Ther 1995; 274: 34–9.
    1. Egan TD, Lemmens HJM, Fiset P, et al. The pharmacokinetics of the new short-acting opioid remifentanil (GI87084B) in healthy adult male volunteers. Anesthesiology 1993; 79: 881–92.
    1. Glass PSA, Hardman D, Kamiyama Y, et al. Preliminary pharmacokinetics and pharmacodynamics of an ultra-short-acting opioid: remifentanil (GI87084B). Anesth Analg 1993; 77: 1031–40.

MeSH terms

LinkOut - more resources